Package 0378-4890-93

{"route": ["ORAL"], "spl_id": "750bda83-d972-44e2-85ae-26676e1e7c34", "openfda": {"nui": ["N0000175463", "N0000175460", "N0000009948", "N0000190118", "N0000187064"], "upc": ["0303784890936"], "unii": ["99DK7FVK1H"], "rxcui": ["1095712"], "spl_set_id": ["690da74b-2481-47fc-93ae-8340e0caf0a4"], "pharm_class_epc": ["Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0378-4890-93)", "package_ndc": "0378-4890-93", "marketing_start_date": "20141029"}], "brand_name": "Nevirapine", "product_id": "0378-4890_750bda83-d972-44e2-85ae-26676e1e7c34", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Non-Nucleoside Analog [EXT]", "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "0378-4890", "generic_name": "nevirapine", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nevirapine", "active_ingredients": [{"name": "NEVIRAPINE", "strength": "400 mg/1"}], "application_number": "ANDA205651", "marketing_category": "ANDA", "marketing_start_date": "20141029", "listing_expiration_date": "20261231"}